Acologix
Biopharmaceutical company developing therapeutic compounds for the treatment of osteo-renal diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| N/A | $30.0m | Series C | |
| Total Funding | 000k | ||
Related Content
Acologix, Inc. is a biopharmaceutical company that identifies, develops, and commercializes therapeutic compounds for the treatment of osteo-renal diseases. The company's focus is on therapies for diseases related to bone and mineral metabolism.
Acologix's primary area of expertise lies in mineral metabolism, and it leverages this to develop biopharmaceuticals. The company's business model revolves around the entire lifecycle of drug development, from identification of promising compounds to their eventual commercialization. The target market for Acologix's products are patients suffering from osteo-renal conditions, and the company operates within the broader biopharmaceutical and healthcare industry.
Keywords: biopharmaceutical, osteo-renal, therapeutic compounds, mineral metabolism, drug development, commercialization, bone disease, kidney disease, healthcare, life sciences